MSCs derived extracellular vesicles as a therapeutic paragon for neurodegenerative disorders: A viewpoint

YASHVI SHARMA, SHARDA RAY, SUJATA MOHANTY
2022 Biocell (Mendoza)  
Neurodegenerative disorders are a vicious woe to the public health and wellness. Uncertainty in their underlying causes, lack of effective biomarkers for their early detection, existence of only supportive therapy, and their ever rising incidence creates an unmatched need for targeted therapies. Mesenchymal Stem Cells (MSCs) have found to be promising candidates for regenerative and remedial therapy in neurodegenerative disorders, however several biological risks and practical issues impede in
more » ... heir translational utility. Deriving from MSCs are certain Extracellular Vesicles (EVs), which aid in the paracrine action of MSCs and have lately gained the scientific interest for their implacability in diverse set ups. Their cargo is of utmost importance and is being explored in various different diseases like heart diseases, neuronal diseases, respiratory diseases and hepatic diseases. They thereby hold the position of a likely prospective remedial candidate for therapy against neurodegenerative disorders.
doi:10.32604/biocell.2022.018612 fatcat:3lupxxsscvg5tb3tme7fwzhw3a